2m 2m 2m 2m 2m 2m 2m
Collegium Pharma (COLL)
NASDAQ
$35.54+$0.15 (+0.44%)
Price as of Aug 03, 2026 9:13 AM EDT- $1.1BMarket Cap
- 17.69%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Collegium Pharma (COLL)
$35.54+$0.15 (+0.44%)
COLL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $35.39 | ||
Change | -$0.59 (-1.64%) | ||
Open | $35.71 | ||
High | $36.28 | ||
Low | $34.40 | ||
Previous Close | $35.98 | ||
Volume | 288,493 | ||
30-Day Average Volume | 376,585 | ||
1-Week Change | 0.54% | ||
1-Month Change | -2.24% | ||
1-Year Change | 17.69% | ||
3-Year Change | 55.49% | ||
5-Year Change | 42.19% | ||
Fundamentals | |||
Shares Outstanding | 32.4M | ||
Total Assets | $1.7B | ||
Market Cap | $1.1B | ||
Enterprise Value | $1.7B | ||
Period: QTR TTM FY | |||
Revenue | $193.5M | ||
Net Income | $14.5M | ||
Free Cash Flow | $56.8M | ||
EBIT | $28.8M | ||
EBITDA | $84.2M | ||
Net Working Capital | $310.7M | ||
EPS | $0.40 | ||
Enterprise Value/EBITDA | 20 | ||
Enterprise Value/Revenue | 9 | ||
P/B | 4 | ||
P/E | 88 | ||
PEG | 8 | ||
Price/Free Cash Flow | 20 | ||
Price/Operating Cash Flow | 20 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue